Home > Insider Trading > Filing (0001179110-12-010990)

Filing Details

Accession Number:: 0001179110-12-010990
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-02 17:53:17
Reporting Period:: 2012-06-29

Filing Date:: 2012-07-02
Accepted Time:: 2012-07-02 16:53:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Synta Pharmaceuticals Corp	SNTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325713	Bruce Kovner	C/O Caxton Corporation 731 Alexander Road, Bldg 2 Princeton NJ 08540		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-29	910,000	$5.45	6,816,048	No	4	P	Direct
Common Stock	Disposition	2012-06-29	1,900,000	$0.00	4,916,048	No	5	G	Direct
Common Stock	Acquisiton	2012-06-29	475,000	$0.00	475,000	No	5	G	Indirect	By Kovner 2012-A Synta Investment Trust
Common Stock	Acquisiton	2012-06-29	475,000	$0.00	475,000	No	5	G	Indirect	By Kovner 2012-B Synta Investment Trust
Common Stock	Acquisiton	2012-06-29	475,000	$0.00	475,000	No	5	G	Indirect	By Kovner 2012-C Synta Investment Trust
Common Stock	Acquisiton	2012-06-29	475,000	$0.00	475,000	No	5	G	Indirect	By Kovner 2012-D Synta Investment Trust
Common Stock	Acquisiton	2012-07-01	7,312	$0.00	4,923,360	No	4	A	Direct
Common Stock	Acquisiton	2012-07-01	914	$0.00	4,924,274	No	4	A	Direct
Common Stock	Acquisiton	2012-07-01	914	$0.00	4,925,188	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	5	G	Direct
No	5	G	Indirect	By Kovner 2012-A Synta Investment Trust
No	5	G	Indirect	By Kovner 2012-B Synta Investment Trust
No	5	G	Indirect	By Kovner 2012-C Synta Investment Trust
No	5	G	Indirect	By Kovner 2012-D Synta Investment Trust
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option (Right to Buy)	Acquisiton	2012-07-01	10,000	$0.00	10,000	$5.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2022-07-01	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	125,000	Indirect	By Kovner 2011-A Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-B Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-C Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-D Investment Trust
Common Stock	7,761,716	Indirect	By CxSynta LLC
Common Stock	125,000	Indirect	By Kovner 2011-A Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-B Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-C Investment Trust
Common Stock	125,000	Indirect	By Kovner 2011-D Investment Trust
Common Stock	475,000	Indirect	By Kovner 2012-A Synta Investment Trust
Common Stock	475,000	Indirect	By Kovner 2012-B Synta Investment Trust
Common Stock	475,000	Indirect	By Kovner 2012-C Synta Investment Trust
Common Stock	475,000	Indirect	By Kovner 2012-D Synta Investment Trust
Common Stock	7,761,716	Indirect	By CxSynta LLC

Footnotes

The shares were purchased in multiple transactions at prices ranging from $4.96 to $5.64 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.
The name of the trust reported above corrects a typographical error contained in the name of the trust reported in the Reporting Person's Form 4 filed on January 10, 2012.
These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a director of the Issuer on such date.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a member of the Compensation Committee of the Board of Directors of the Issuer on such date.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a member of the Nominating and Governance Committee of the Board of Directors of the Issuer on such date.
The option vests as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a director of the Issuer on such date.